Global Vaccines Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Vaccines market size was valued at US$ 44300 million in 2023. With growing demand in downstream market, the Vaccines is forecast to a readjusted size of US$ 65770 million by 2030 with a CAGR of 5.8% during review period.
The research report highlights the growth potential of the global Vaccines market. Vaccines are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Vaccines. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Vaccines market.
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and 'remember' it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
The major players in global Vaccines market include Merck, GSK, Sanofi, etc. The top 3 players occupy about 45% shares of the global market. North America and Europe are main markets, they occupy about 65% of the global market. Recombinant Vaccines is the main type, with a share about 35%. Rabies vaccine, Influenza vaccine, HPV vaccine are main applications, which hold a share about 35%.
Key Features:
The report on Vaccines market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Vaccines market. It may include historical data, market segmentation by Type (e.g., Recombinant Vaccines, Viral Vaccines), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Vaccines market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Vaccines market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Vaccines industry. This include advancements in Vaccines technology, Vaccines new entrants, Vaccines new investment, and other innovations that are shaping the future of Vaccines.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Vaccines market. It includes factors influencing customer ' purchasing decisions, preferences for Vaccines product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Vaccines market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Vaccines market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Vaccines market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Vaccines industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Vaccines market.
Market Segmentation:
Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Vaccines market?
What factors are driving Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vaccines market opportunities vary by end market size?
How does Vaccines break out type, application?
According to our LPI (LP Information) latest study, the global Vaccines market size was valued at US$ 44300 million in 2023. With growing demand in downstream market, the Vaccines is forecast to a readjusted size of US$ 65770 million by 2030 with a CAGR of 5.8% during review period.
The research report highlights the growth potential of the global Vaccines market. Vaccines are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Vaccines. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Vaccines market.
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and 'remember' it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
The major players in global Vaccines market include Merck, GSK, Sanofi, etc. The top 3 players occupy about 45% shares of the global market. North America and Europe are main markets, they occupy about 65% of the global market. Recombinant Vaccines is the main type, with a share about 35%. Rabies vaccine, Influenza vaccine, HPV vaccine are main applications, which hold a share about 35%.
Key Features:
The report on Vaccines market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Vaccines market. It may include historical data, market segmentation by Type (e.g., Recombinant Vaccines, Viral Vaccines), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Vaccines market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Vaccines market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Vaccines industry. This include advancements in Vaccines technology, Vaccines new entrants, Vaccines new investment, and other innovations that are shaping the future of Vaccines.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Vaccines market. It includes factors influencing customer ' purchasing decisions, preferences for Vaccines product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Vaccines market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Vaccines market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Vaccines market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Vaccines industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Vaccines market.
Market Segmentation:
Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Recombinant Vaccines
- Viral Vaccines
- Polysaccharide Vaccines
- Others
- Rabies vaccine
- Influenza vaccine
- HPV vaccine
- Hepatitis B
- Hepatitis A
- Leprosy vaccine
- Polio vaccine
- JE vaccine
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GSK
- Sanofi
- Merck
- Pfizer
- Novartis(GSK)
- CSL
- MedImmune LLC
- J&J(Crucell)
- China National Biotec
- Tiantan
- Hualan
- Kangtai
- Hissen
- Jintan
What is the 10-year outlook for the global Vaccines market?
What factors are driving Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vaccines market opportunities vary by end market size?
How does Vaccines break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vaccines Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Vaccines by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Vaccines by Country/Region, 2019, 2023 & 2030
2.2 Vaccines Segment by Type
2.2.1 Recombinant Vaccines
2.2.2 Viral Vaccines
2.2.3 Polysaccharide Vaccines
2.2.4 Others
2.3 Vaccines Sales by Type
2.3.1 Global Vaccines Sales Market Share by Type (2019-2024)
2.3.2 Global Vaccines Revenue and Market Share by Type (2019-2024)
2.3.3 Global Vaccines Sale Price by Type (2019-2024)
2.4 Vaccines Segment by Application
2.4.1 Rabies vaccine
2.4.2 Influenza vaccine
2.4.3 HPV vaccine
2.4.4 Hepatitis B
2.4.5 Hepatitis A
2.4.6 Leprosy vaccine
2.4.7 Polio vaccine
2.4.8 JE vaccine
2.4.9 Others
2.5 Vaccines Sales by Application
2.5.1 Global Vaccines Sale Market Share by Application (2019-2024)
2.5.2 Global Vaccines Revenue and Market Share by Application (2019-2024)
2.5.3 Global Vaccines Sale Price by Application (2019-2024)
3 GLOBAL VACCINES BY COMPANY
3.1 Global Vaccines Breakdown Data by Company
3.1.1 Global Vaccines Annual Sales by Company (2019-2024)
3.1.2 Global Vaccines Sales Market Share by Company (2019-2024)
3.2 Global Vaccines Annual Revenue by Company (2019-2024)
3.2.1 Global Vaccines Revenue by Company (2019-2024)
3.2.2 Global Vaccines Revenue Market Share by Company (2019-2024)
3.3 Global Vaccines Sale Price by Company
3.4 Key Manufacturers Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vaccines Product Location Distribution
3.4.2 Players Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Vaccines Market Size by Geographic Region (2019-2024)
4.1.1 Global Vaccines Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Vaccines Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Vaccines Market Size by Country/Region (2019-2024)
4.2.1 Global Vaccines Annual Sales by Country/Region (2019-2024)
4.2.2 Global Vaccines Annual Revenue by Country/Region (2019-2024)
4.3 Americas Vaccines Sales Growth
4.4 APAC Vaccines Sales Growth
4.5 Europe Vaccines Sales Growth
4.6 Middle East & Africa Vaccines Sales Growth
5 AMERICAS
5.1 Americas Vaccines Sales by Country
5.1.1 Americas Vaccines Sales by Country (2019-2024)
5.1.2 Americas Vaccines Revenue by Country (2019-2024)
5.2 Americas Vaccines Sales by Type
5.3 Americas Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccines Sales by Region
6.1.1 APAC Vaccines Sales by Region (2019-2024)
6.1.2 APAC Vaccines Revenue by Region (2019-2024)
6.2 APAC Vaccines Sales by Type
6.3 APAC Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Vaccines by Country
7.1.1 Europe Vaccines Sales by Country (2019-2024)
7.1.2 Europe Vaccines Revenue by Country (2019-2024)
7.2 Europe Vaccines Sales by Type
7.3 Europe Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vaccines by Country
8.1.1 Middle East & Africa Vaccines Sales by Country (2019-2024)
8.1.2 Middle East & Africa Vaccines Revenue by Country (2019-2024)
8.2 Middle East & Africa Vaccines Sales by Type
8.3 Middle East & Africa Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vaccines
10.3 Manufacturing Process Analysis of Vaccines
10.4 Industry Chain Structure of Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vaccines Distributors
11.3 Vaccines Customer
12 WORLD FORECAST REVIEW FOR VACCINES BY GEOGRAPHIC REGION
12.1 Global Vaccines Market Size Forecast by Region
12.1.1 Global Vaccines Forecast by Region (2025-2030)
12.1.2 Global Vaccines Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Vaccines Forecast by Type
12.7 Global Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Vaccines Product Portfolios and Specifications
13.1.3 GSK Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Vaccines Product Portfolios and Specifications
13.2.3 Sanofi Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Vaccines Product Portfolios and Specifications
13.3.3 Merck Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Vaccines Product Portfolios and Specifications
13.4.3 Pfizer Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Novartis(GSK)
13.5.1 Novartis(GSK) Company Information
13.5.2 Novartis(GSK) Vaccines Product Portfolios and Specifications
13.5.3 Novartis(GSK) Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Novartis(GSK) Main Business Overview
13.5.5 Novartis(GSK) Latest Developments
13.6 CSL
13.6.1 CSL Company Information
13.6.2 CSL Vaccines Product Portfolios and Specifications
13.6.3 CSL Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 CSL Main Business Overview
13.6.5 CSL Latest Developments
13.7 MedImmune LLC
13.7.1 MedImmune LLC Company Information
13.7.2 MedImmune LLC Vaccines Product Portfolios and Specifications
13.7.3 MedImmune LLC Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 MedImmune LLC Main Business Overview
13.7.5 MedImmune LLC Latest Developments
13.8 J&J(Crucell)
13.8.1 J&J(Crucell) Company Information
13.8.2 J&J(Crucell) Vaccines Product Portfolios and Specifications
13.8.3 J&J(Crucell) Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 J&J(Crucell) Main Business Overview
13.8.5 J&J(Crucell) Latest Developments
13.9 China National Biotec
13.9.1 China National Biotec Company Information
13.9.2 China National Biotec Vaccines Product Portfolios and Specifications
13.9.3 China National Biotec Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 China National Biotec Main Business Overview
13.9.5 China National Biotec Latest Developments
13.10 Tiantan
13.10.1 Tiantan Company Information
13.10.2 Tiantan Vaccines Product Portfolios and Specifications
13.10.3 Tiantan Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Tiantan Main Business Overview
13.10.5 Tiantan Latest Developments
13.11 Hualan
13.11.1 Hualan Company Information
13.11.2 Hualan Vaccines Product Portfolios and Specifications
13.11.3 Hualan Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Hualan Main Business Overview
13.11.5 Hualan Latest Developments
13.12 Kangtai
13.12.1 Kangtai Company Information
13.12.2 Kangtai Vaccines Product Portfolios and Specifications
13.12.3 Kangtai Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Kangtai Main Business Overview
13.12.5 Kangtai Latest Developments
13.13 Hissen
13.13.1 Hissen Company Information
13.13.2 Hissen Vaccines Product Portfolios and Specifications
13.13.3 Hissen Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Hissen Main Business Overview
13.13.5 Hissen Latest Developments
13.14 Jintan
13.14.1 Jintan Company Information
13.14.2 Jintan Vaccines Product Portfolios and Specifications
13.14.3 Jintan Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Jintan Main Business Overview
13.14.5 Jintan Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vaccines Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Vaccines by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Vaccines by Country/Region, 2019, 2023 & 2030
2.2 Vaccines Segment by Type
2.2.1 Recombinant Vaccines
2.2.2 Viral Vaccines
2.2.3 Polysaccharide Vaccines
2.2.4 Others
2.3 Vaccines Sales by Type
2.3.1 Global Vaccines Sales Market Share by Type (2019-2024)
2.3.2 Global Vaccines Revenue and Market Share by Type (2019-2024)
2.3.3 Global Vaccines Sale Price by Type (2019-2024)
2.4 Vaccines Segment by Application
2.4.1 Rabies vaccine
2.4.2 Influenza vaccine
2.4.3 HPV vaccine
2.4.4 Hepatitis B
2.4.5 Hepatitis A
2.4.6 Leprosy vaccine
2.4.7 Polio vaccine
2.4.8 JE vaccine
2.4.9 Others
2.5 Vaccines Sales by Application
2.5.1 Global Vaccines Sale Market Share by Application (2019-2024)
2.5.2 Global Vaccines Revenue and Market Share by Application (2019-2024)
2.5.3 Global Vaccines Sale Price by Application (2019-2024)
3 GLOBAL VACCINES BY COMPANY
3.1 Global Vaccines Breakdown Data by Company
3.1.1 Global Vaccines Annual Sales by Company (2019-2024)
3.1.2 Global Vaccines Sales Market Share by Company (2019-2024)
3.2 Global Vaccines Annual Revenue by Company (2019-2024)
3.2.1 Global Vaccines Revenue by Company (2019-2024)
3.2.2 Global Vaccines Revenue Market Share by Company (2019-2024)
3.3 Global Vaccines Sale Price by Company
3.4 Key Manufacturers Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vaccines Product Location Distribution
3.4.2 Players Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Vaccines Market Size by Geographic Region (2019-2024)
4.1.1 Global Vaccines Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Vaccines Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Vaccines Market Size by Country/Region (2019-2024)
4.2.1 Global Vaccines Annual Sales by Country/Region (2019-2024)
4.2.2 Global Vaccines Annual Revenue by Country/Region (2019-2024)
4.3 Americas Vaccines Sales Growth
4.4 APAC Vaccines Sales Growth
4.5 Europe Vaccines Sales Growth
4.6 Middle East & Africa Vaccines Sales Growth
5 AMERICAS
5.1 Americas Vaccines Sales by Country
5.1.1 Americas Vaccines Sales by Country (2019-2024)
5.1.2 Americas Vaccines Revenue by Country (2019-2024)
5.2 Americas Vaccines Sales by Type
5.3 Americas Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccines Sales by Region
6.1.1 APAC Vaccines Sales by Region (2019-2024)
6.1.2 APAC Vaccines Revenue by Region (2019-2024)
6.2 APAC Vaccines Sales by Type
6.3 APAC Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Vaccines by Country
7.1.1 Europe Vaccines Sales by Country (2019-2024)
7.1.2 Europe Vaccines Revenue by Country (2019-2024)
7.2 Europe Vaccines Sales by Type
7.3 Europe Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vaccines by Country
8.1.1 Middle East & Africa Vaccines Sales by Country (2019-2024)
8.1.2 Middle East & Africa Vaccines Revenue by Country (2019-2024)
8.2 Middle East & Africa Vaccines Sales by Type
8.3 Middle East & Africa Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vaccines
10.3 Manufacturing Process Analysis of Vaccines
10.4 Industry Chain Structure of Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vaccines Distributors
11.3 Vaccines Customer
12 WORLD FORECAST REVIEW FOR VACCINES BY GEOGRAPHIC REGION
12.1 Global Vaccines Market Size Forecast by Region
12.1.1 Global Vaccines Forecast by Region (2025-2030)
12.1.2 Global Vaccines Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Vaccines Forecast by Type
12.7 Global Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Vaccines Product Portfolios and Specifications
13.1.3 GSK Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Vaccines Product Portfolios and Specifications
13.2.3 Sanofi Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Vaccines Product Portfolios and Specifications
13.3.3 Merck Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Vaccines Product Portfolios and Specifications
13.4.3 Pfizer Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Novartis(GSK)
13.5.1 Novartis(GSK) Company Information
13.5.2 Novartis(GSK) Vaccines Product Portfolios and Specifications
13.5.3 Novartis(GSK) Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Novartis(GSK) Main Business Overview
13.5.5 Novartis(GSK) Latest Developments
13.6 CSL
13.6.1 CSL Company Information
13.6.2 CSL Vaccines Product Portfolios and Specifications
13.6.3 CSL Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 CSL Main Business Overview
13.6.5 CSL Latest Developments
13.7 MedImmune LLC
13.7.1 MedImmune LLC Company Information
13.7.2 MedImmune LLC Vaccines Product Portfolios and Specifications
13.7.3 MedImmune LLC Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 MedImmune LLC Main Business Overview
13.7.5 MedImmune LLC Latest Developments
13.8 J&J(Crucell)
13.8.1 J&J(Crucell) Company Information
13.8.2 J&J(Crucell) Vaccines Product Portfolios and Specifications
13.8.3 J&J(Crucell) Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 J&J(Crucell) Main Business Overview
13.8.5 J&J(Crucell) Latest Developments
13.9 China National Biotec
13.9.1 China National Biotec Company Information
13.9.2 China National Biotec Vaccines Product Portfolios and Specifications
13.9.3 China National Biotec Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 China National Biotec Main Business Overview
13.9.5 China National Biotec Latest Developments
13.10 Tiantan
13.10.1 Tiantan Company Information
13.10.2 Tiantan Vaccines Product Portfolios and Specifications
13.10.3 Tiantan Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Tiantan Main Business Overview
13.10.5 Tiantan Latest Developments
13.11 Hualan
13.11.1 Hualan Company Information
13.11.2 Hualan Vaccines Product Portfolios and Specifications
13.11.3 Hualan Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Hualan Main Business Overview
13.11.5 Hualan Latest Developments
13.12 Kangtai
13.12.1 Kangtai Company Information
13.12.2 Kangtai Vaccines Product Portfolios and Specifications
13.12.3 Kangtai Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Kangtai Main Business Overview
13.12.5 Kangtai Latest Developments
13.13 Hissen
13.13.1 Hissen Company Information
13.13.2 Hissen Vaccines Product Portfolios and Specifications
13.13.3 Hissen Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Hissen Main Business Overview
13.13.5 Hissen Latest Developments
13.14 Jintan
13.14.1 Jintan Company Information
13.14.2 Jintan Vaccines Product Portfolios and Specifications
13.14.3 Jintan Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Jintan Main Business Overview
13.14.5 Jintan Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Vaccines Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Vaccines Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Recombinant Vaccines
Table 4. Major Players of Viral Vaccines
Table 5. Major Players of Polysaccharide Vaccines
Table 6. Major Players of Others
Table 7. Global Vaccines Sales by Type (2019-2024) & (K Units)
Table 8. Global Vaccines Sales Market Share by Type (2019-2024)
Table 9. Global Vaccines Revenue by Type (2019-2024) & ($ million)
Table 10. Global Vaccines Revenue Market Share by Type (2019-2024)
Table 11. Global Vaccines Sale Price by Type (2019-2024) & (USD/Unit)
Table 12. Global Vaccines Sales by Application (2019-2024) & (K Units)
Table 13. Global Vaccines Sales Market Share by Application (2019-2024)
Table 14. Global Vaccines Revenue by Application (2019-2024)
Table 15. Global Vaccines Revenue Market Share by Application (2019-2024)
Table 16. Global Vaccines Sale Price by Application (2019-2024) & (USD/Unit)
Table 17. Global Vaccines Sales by Company (2019-2024) & (K Units)
Table 18. Global Vaccines Sales Market Share by Company (2019-2024)
Table 19. Global Vaccines Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Vaccines Revenue Market Share by Company (2019-2024)
Table 21. Global Vaccines Sale Price by Company (2019-2024) & (USD/Unit)
Table 22. Key Manufacturers Vaccines Producing Area Distribution and Sales Area
Table 23. Players Vaccines Products Offered
Table 24. Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Vaccines Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Vaccines Sales Market Share Geographic Region (2019-2024)
Table 29. Global Vaccines Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Vaccines Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Vaccines Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Vaccines Sales Market Share by Country/Region (2019-2024)
Table 33. Global Vaccines Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Vaccines Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Vaccines Sales by Country (2019-2024) & (K Units)
Table 36. Americas Vaccines Sales Market Share by Country (2019-2024)
Table 37. Americas Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Vaccines Revenue Market Share by Country (2019-2024)
Table 39. Americas Vaccines Sales by Type (2019-2024) & (K Units)
Table 40. Americas Vaccines Sales by Application (2019-2024) & (K Units)
Table 41. APAC Vaccines Sales by Region (2019-2024) & (K Units)
Table 42. APAC Vaccines Sales Market Share by Region (2019-2024)
Table 43. APAC Vaccines Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Vaccines Revenue Market Share by Region (2019-2024)
Table 45. APAC Vaccines Sales by Type (2019-2024) & (K Units)
Table 46. APAC Vaccines Sales by Application (2019-2024) & (K Units)
Table 47. Europe Vaccines Sales by Country (2019-2024) & (K Units)
Table 48. Europe Vaccines Sales Market Share by Country (2019-2024)
Table 49. Europe Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Vaccines Revenue Market Share by Country (2019-2024)
Table 51. Europe Vaccines Sales by Type (2019-2024) & (K Units)
Table 52. Europe Vaccines Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa Vaccines Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa Vaccines Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Vaccines Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Vaccines Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa Vaccines Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Vaccines
Table 60. Key Market Challenges & Risks of Vaccines
Table 61. Key Industry Trends of Vaccines
Table 62. Vaccines Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Vaccines Distributors List
Table 65. Vaccines Customer List
Table 66. Global Vaccines Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Vaccines Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Vaccines Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global Vaccines Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Vaccines Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global Vaccines Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. GSK Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 81. GSK Vaccines Product Portfolios and Specifications
Table 82. GSK Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. GSK Main Business
Table 84. GSK Latest Developments
Table 85. Sanofi Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 86. Sanofi Vaccines Product Portfolios and Specifications
Table 87. Sanofi Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Sanofi Main Business
Table 89. Sanofi Latest Developments
Table 90. Merck Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 91. Merck Vaccines Product Portfolios and Specifications
Table 92. Merck Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Merck Main Business
Table 94. Merck Latest Developments
Table 95. Pfizer Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 96. Pfizer Vaccines Product Portfolios and Specifications
Table 97. Pfizer Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Pfizer Main Business
Table 99. Pfizer Latest Developments
Table 100. Novartis(GSK) Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 101. Novartis(GSK) Vaccines Product Portfolios and Specifications
Table 102. Novartis(GSK) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Novartis(GSK) Main Business
Table 104. Novartis(GSK) Latest Developments
Table 105. CSL Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 106. CSL Vaccines Product Portfolios and Specifications
Table 107. CSL Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. CSL Main Business
Table 109. CSL Latest Developments
Table 110. MedImmune LLC Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 111. MedImmune LLC Vaccines Product Portfolios and Specifications
Table 112. MedImmune LLC Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. MedImmune LLC Main Business
Table 114. MedImmune LLC Latest Developments
Table 115. J&J(Crucell) Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 116. J&J(Crucell) Vaccines Product Portfolios and Specifications
Table 117. J&J(Crucell) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. J&J(Crucell) Main Business
Table 119. J&J(Crucell) Latest Developments
Table 120. China National Biotec Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 121. China National Biotec Vaccines Product Portfolios and Specifications
Table 122. China National Biotec Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. China National Biotec Main Business
Table 124. China National Biotec Latest Developments
Table 125. Tiantan Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 126. Tiantan Vaccines Product Portfolios and Specifications
Table 127. Tiantan Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Tiantan Main Business
Table 129. Tiantan Latest Developments
Table 130. Hualan Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 131. Hualan Vaccines Product Portfolios and Specifications
Table 132. Hualan Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Hualan Main Business
Table 134. Hualan Latest Developments
Table 135. Kangtai Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 136. Kangtai Vaccines Product Portfolios and Specifications
Table 137. Kangtai Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Kangtai Main Business
Table 139. Kangtai Latest Developments
Table 140. Hissen Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 141. Hissen Vaccines Product Portfolios and Specifications
Table 142. Hissen Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 143. Hissen Main Business
Table 144. Hissen Latest Developments
Table 145. Jintan Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 146. Jintan Vaccines Product Portfolios and Specifications
Table 147. Jintan Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 148. Jintan Main Business
Table 149. Jintan Latest Developments
Table 1. Vaccines Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Vaccines Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Recombinant Vaccines
Table 4. Major Players of Viral Vaccines
Table 5. Major Players of Polysaccharide Vaccines
Table 6. Major Players of Others
Table 7. Global Vaccines Sales by Type (2019-2024) & (K Units)
Table 8. Global Vaccines Sales Market Share by Type (2019-2024)
Table 9. Global Vaccines Revenue by Type (2019-2024) & ($ million)
Table 10. Global Vaccines Revenue Market Share by Type (2019-2024)
Table 11. Global Vaccines Sale Price by Type (2019-2024) & (USD/Unit)
Table 12. Global Vaccines Sales by Application (2019-2024) & (K Units)
Table 13. Global Vaccines Sales Market Share by Application (2019-2024)
Table 14. Global Vaccines Revenue by Application (2019-2024)
Table 15. Global Vaccines Revenue Market Share by Application (2019-2024)
Table 16. Global Vaccines Sale Price by Application (2019-2024) & (USD/Unit)
Table 17. Global Vaccines Sales by Company (2019-2024) & (K Units)
Table 18. Global Vaccines Sales Market Share by Company (2019-2024)
Table 19. Global Vaccines Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Vaccines Revenue Market Share by Company (2019-2024)
Table 21. Global Vaccines Sale Price by Company (2019-2024) & (USD/Unit)
Table 22. Key Manufacturers Vaccines Producing Area Distribution and Sales Area
Table 23. Players Vaccines Products Offered
Table 24. Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Vaccines Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Vaccines Sales Market Share Geographic Region (2019-2024)
Table 29. Global Vaccines Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Vaccines Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Vaccines Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Vaccines Sales Market Share by Country/Region (2019-2024)
Table 33. Global Vaccines Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Vaccines Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Vaccines Sales by Country (2019-2024) & (K Units)
Table 36. Americas Vaccines Sales Market Share by Country (2019-2024)
Table 37. Americas Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Vaccines Revenue Market Share by Country (2019-2024)
Table 39. Americas Vaccines Sales by Type (2019-2024) & (K Units)
Table 40. Americas Vaccines Sales by Application (2019-2024) & (K Units)
Table 41. APAC Vaccines Sales by Region (2019-2024) & (K Units)
Table 42. APAC Vaccines Sales Market Share by Region (2019-2024)
Table 43. APAC Vaccines Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Vaccines Revenue Market Share by Region (2019-2024)
Table 45. APAC Vaccines Sales by Type (2019-2024) & (K Units)
Table 46. APAC Vaccines Sales by Application (2019-2024) & (K Units)
Table 47. Europe Vaccines Sales by Country (2019-2024) & (K Units)
Table 48. Europe Vaccines Sales Market Share by Country (2019-2024)
Table 49. Europe Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Vaccines Revenue Market Share by Country (2019-2024)
Table 51. Europe Vaccines Sales by Type (2019-2024) & (K Units)
Table 52. Europe Vaccines Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa Vaccines Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa Vaccines Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Vaccines Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Vaccines Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa Vaccines Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Vaccines
Table 60. Key Market Challenges & Risks of Vaccines
Table 61. Key Industry Trends of Vaccines
Table 62. Vaccines Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Vaccines Distributors List
Table 65. Vaccines Customer List
Table 66. Global Vaccines Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Vaccines Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Vaccines Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global Vaccines Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Vaccines Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global Vaccines Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. GSK Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 81. GSK Vaccines Product Portfolios and Specifications
Table 82. GSK Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. GSK Main Business
Table 84. GSK Latest Developments
Table 85. Sanofi Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 86. Sanofi Vaccines Product Portfolios and Specifications
Table 87. Sanofi Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Sanofi Main Business
Table 89. Sanofi Latest Developments
Table 90. Merck Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 91. Merck Vaccines Product Portfolios and Specifications
Table 92. Merck Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Merck Main Business
Table 94. Merck Latest Developments
Table 95. Pfizer Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 96. Pfizer Vaccines Product Portfolios and Specifications
Table 97. Pfizer Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Pfizer Main Business
Table 99. Pfizer Latest Developments
Table 100. Novartis(GSK) Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 101. Novartis(GSK) Vaccines Product Portfolios and Specifications
Table 102. Novartis(GSK) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Novartis(GSK) Main Business
Table 104. Novartis(GSK) Latest Developments
Table 105. CSL Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 106. CSL Vaccines Product Portfolios and Specifications
Table 107. CSL Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. CSL Main Business
Table 109. CSL Latest Developments
Table 110. MedImmune LLC Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 111. MedImmune LLC Vaccines Product Portfolios and Specifications
Table 112. MedImmune LLC Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. MedImmune LLC Main Business
Table 114. MedImmune LLC Latest Developments
Table 115. J&J(Crucell) Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 116. J&J(Crucell) Vaccines Product Portfolios and Specifications
Table 117. J&J(Crucell) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. J&J(Crucell) Main Business
Table 119. J&J(Crucell) Latest Developments
Table 120. China National Biotec Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 121. China National Biotec Vaccines Product Portfolios and Specifications
Table 122. China National Biotec Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. China National Biotec Main Business
Table 124. China National Biotec Latest Developments
Table 125. Tiantan Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 126. Tiantan Vaccines Product Portfolios and Specifications
Table 127. Tiantan Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Tiantan Main Business
Table 129. Tiantan Latest Developments
Table 130. Hualan Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 131. Hualan Vaccines Product Portfolios and Specifications
Table 132. Hualan Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Hualan Main Business
Table 134. Hualan Latest Developments
Table 135. Kangtai Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 136. Kangtai Vaccines Product Portfolios and Specifications
Table 137. Kangtai Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Kangtai Main Business
Table 139. Kangtai Latest Developments
Table 140. Hissen Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 141. Hissen Vaccines Product Portfolios and Specifications
Table 142. Hissen Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 143. Hissen Main Business
Table 144. Hissen Latest Developments
Table 145. Jintan Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 146. Jintan Vaccines Product Portfolios and Specifications
Table 147. Jintan Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 148. Jintan Main Business
Table 149. Jintan Latest Developments
LIST OF FIGURES
Figure 1. Picture of Vaccines
Figure 2. Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vaccines Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Vaccines Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Vaccines Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Recombinant Vaccines
Figure 10. Product Picture of Viral Vaccines
Figure 11. Product Picture of Polysaccharide Vaccines
Figure 12. Product Picture of Others
Figure 13. Global Vaccines Sales Market Share by Type in 2023
Figure 14. Global Vaccines Revenue Market Share by Type (2019-2024)
Figure 15. Vaccines Consumed in Rabies vaccine
Figure 16. Global Vaccines Market: Rabies vaccine (2019-2024) & (K Units)
Figure 17. Vaccines Consumed in Influenza vaccine
Figure 18. Global Vaccines Market: Influenza vaccine (2019-2024) & (K Units)
Figure 19. Vaccines Consumed in HPV vaccine
Figure 20. Global Vaccines Market: HPV vaccine (2019-2024) & (K Units)
Figure 21. Vaccines Consumed in Hepatitis B
Figure 22. Global Vaccines Market: Hepatitis B (2019-2024) & (K Units)
Figure 23. Vaccines Consumed in Hepatitis A
Figure 24. Global Vaccines Market: Hepatitis A (2019-2024) & (K Units)
Figure 25. Vaccines Consumed in Leprosy vaccine
Figure 26. Global Vaccines Market: Leprosy vaccine (2019-2024) & (K Units)
Figure 27. Vaccines Consumed in Polio vaccine
Figure 28. Global Vaccines Market: Polio vaccine (2019-2024) & (K Units)
Figure 29. Vaccines Consumed in JE vaccine
Figure 30. Global Vaccines Market: JE vaccine (2019-2024) & (K Units)
Figure 31. Vaccines Consumed in Others
Figure 32. Global Vaccines Market: Others (2019-2024) & (K Units)
Figure 33. Global Vaccines Sales Market Share by Application (2023)
Figure 34. Global Vaccines Revenue Market Share by Application in 2023
Figure 35. Vaccines Sales Market by Company in 2023 (K Units)
Figure 36. Global Vaccines Sales Market Share by Company in 2023
Figure 37. Vaccines Revenue Market by Company in 2023 ($ Million)
Figure 38. Global Vaccines Revenue Market Share by Company in 2023
Figure 39. Global Vaccines Sales Market Share by Geographic Region (2019-2024)
Figure 40. Global Vaccines Revenue Market Share by Geographic Region in 2023
Figure 41. Americas Vaccines Sales 2019-2024 (K Units)
Figure 42. Americas Vaccines Revenue 2019-2024 ($ Millions)
Figure 43. APAC Vaccines Sales 2019-2024 (K Units)
Figure 44. APAC Vaccines Revenue 2019-2024 ($ Millions)
Figure 45. Europe Vaccines Sales 2019-2024 (K Units)
Figure 46. Europe Vaccines Revenue 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Vaccines Sales 2019-2024 (K Units)
Figure 48. Middle East & Africa Vaccines Revenue 2019-2024 ($ Millions)
Figure 49. Americas Vaccines Sales Market Share by Country in 2023
Figure 50. Americas Vaccines Revenue Market Share by Country in 2023
Figure 51. Americas Vaccines Sales Market Share by Type (2019-2024)
Figure 52. Americas Vaccines Sales Market Share by Application (2019-2024)
Figure 53. United States Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 54. Canada Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 55. Mexico Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 56. Brazil Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 57. APAC Vaccines Sales Market Share by Region in 2023
Figure 58. APAC Vaccines Revenue Market Share by Regions in 2023
Figure 59. APAC Vaccines Sales Market Share by Type (2019-2024)
Figure 60. APAC Vaccines Sales Market Share by Application (2019-2024)
Figure 61. China Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 62. Japan Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 63. South Korea Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 64. Southeast Asia Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 65. India Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 66. Australia Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 67. China Taiwan Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 68. Europe Vaccines Sales Market Share by Country in 2023
Figure 69. Europe Vaccines Revenue Market Share by Country in 2023
Figure 70. Europe Vaccines Sales Market Share by Type (2019-2024)
Figure 71. Europe Vaccines Sales Market Share by Application (2019-2024)
Figure 72. Germany Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 73. France Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 74. UK Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 75. Italy Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 76. Russia Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 77. Middle East & Africa Vaccines Sales Market Share by Country in 2023
Figure 78. Middle East & Africa Vaccines Revenue Market Share by Country in 2023
Figure 79. Middle East & Africa Vaccines Sales Market Share by Type (2019-2024)
Figure 80. Middle East & Africa Vaccines Sales Market Share by Application (2019-2024)
Figure 81. Egypt Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 82. South Africa Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 83. Israel Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 84. Turkey Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 85. GCC Country Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 86. Manufacturing Cost Structure Analysis of Vaccines in 2023
Figure 87. Manufacturing Process Analysis of Vaccines
Figure 88. Industry Chain Structure of Vaccines
Figure 89. Channels of Distribution
Figure 90. Global Vaccines Sales Market Forecast by Region (2025-2030)
Figure 91. Global Vaccines Revenue Market Share Forecast by Region (2025-2030)
Figure 92. Global Vaccines Sales Market Share Forecast by Type (2025-2030)
Figure 93. Global Vaccines Revenue Market Share Forecast by Type (2025-2030)
Figure 94. Global Vaccines Sales Market Share Forecast by Application (2025-2030)
Figure 95. Global Vaccines Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Vaccines
Figure 2. Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vaccines Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Vaccines Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Vaccines Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Recombinant Vaccines
Figure 10. Product Picture of Viral Vaccines
Figure 11. Product Picture of Polysaccharide Vaccines
Figure 12. Product Picture of Others
Figure 13. Global Vaccines Sales Market Share by Type in 2023
Figure 14. Global Vaccines Revenue Market Share by Type (2019-2024)
Figure 15. Vaccines Consumed in Rabies vaccine
Figure 16. Global Vaccines Market: Rabies vaccine (2019-2024) & (K Units)
Figure 17. Vaccines Consumed in Influenza vaccine
Figure 18. Global Vaccines Market: Influenza vaccine (2019-2024) & (K Units)
Figure 19. Vaccines Consumed in HPV vaccine
Figure 20. Global Vaccines Market: HPV vaccine (2019-2024) & (K Units)
Figure 21. Vaccines Consumed in Hepatitis B
Figure 22. Global Vaccines Market: Hepatitis B (2019-2024) & (K Units)
Figure 23. Vaccines Consumed in Hepatitis A
Figure 24. Global Vaccines Market: Hepatitis A (2019-2024) & (K Units)
Figure 25. Vaccines Consumed in Leprosy vaccine
Figure 26. Global Vaccines Market: Leprosy vaccine (2019-2024) & (K Units)
Figure 27. Vaccines Consumed in Polio vaccine
Figure 28. Global Vaccines Market: Polio vaccine (2019-2024) & (K Units)
Figure 29. Vaccines Consumed in JE vaccine
Figure 30. Global Vaccines Market: JE vaccine (2019-2024) & (K Units)
Figure 31. Vaccines Consumed in Others
Figure 32. Global Vaccines Market: Others (2019-2024) & (K Units)
Figure 33. Global Vaccines Sales Market Share by Application (2023)
Figure 34. Global Vaccines Revenue Market Share by Application in 2023
Figure 35. Vaccines Sales Market by Company in 2023 (K Units)
Figure 36. Global Vaccines Sales Market Share by Company in 2023
Figure 37. Vaccines Revenue Market by Company in 2023 ($ Million)
Figure 38. Global Vaccines Revenue Market Share by Company in 2023
Figure 39. Global Vaccines Sales Market Share by Geographic Region (2019-2024)
Figure 40. Global Vaccines Revenue Market Share by Geographic Region in 2023
Figure 41. Americas Vaccines Sales 2019-2024 (K Units)
Figure 42. Americas Vaccines Revenue 2019-2024 ($ Millions)
Figure 43. APAC Vaccines Sales 2019-2024 (K Units)
Figure 44. APAC Vaccines Revenue 2019-2024 ($ Millions)
Figure 45. Europe Vaccines Sales 2019-2024 (K Units)
Figure 46. Europe Vaccines Revenue 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Vaccines Sales 2019-2024 (K Units)
Figure 48. Middle East & Africa Vaccines Revenue 2019-2024 ($ Millions)
Figure 49. Americas Vaccines Sales Market Share by Country in 2023
Figure 50. Americas Vaccines Revenue Market Share by Country in 2023
Figure 51. Americas Vaccines Sales Market Share by Type (2019-2024)
Figure 52. Americas Vaccines Sales Market Share by Application (2019-2024)
Figure 53. United States Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 54. Canada Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 55. Mexico Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 56. Brazil Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 57. APAC Vaccines Sales Market Share by Region in 2023
Figure 58. APAC Vaccines Revenue Market Share by Regions in 2023
Figure 59. APAC Vaccines Sales Market Share by Type (2019-2024)
Figure 60. APAC Vaccines Sales Market Share by Application (2019-2024)
Figure 61. China Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 62. Japan Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 63. South Korea Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 64. Southeast Asia Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 65. India Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 66. Australia Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 67. China Taiwan Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 68. Europe Vaccines Sales Market Share by Country in 2023
Figure 69. Europe Vaccines Revenue Market Share by Country in 2023
Figure 70. Europe Vaccines Sales Market Share by Type (2019-2024)
Figure 71. Europe Vaccines Sales Market Share by Application (2019-2024)
Figure 72. Germany Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 73. France Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 74. UK Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 75. Italy Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 76. Russia Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 77. Middle East & Africa Vaccines Sales Market Share by Country in 2023
Figure 78. Middle East & Africa Vaccines Revenue Market Share by Country in 2023
Figure 79. Middle East & Africa Vaccines Sales Market Share by Type (2019-2024)
Figure 80. Middle East & Africa Vaccines Sales Market Share by Application (2019-2024)
Figure 81. Egypt Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 82. South Africa Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 83. Israel Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 84. Turkey Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 85. GCC Country Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 86. Manufacturing Cost Structure Analysis of Vaccines in 2023
Figure 87. Manufacturing Process Analysis of Vaccines
Figure 88. Industry Chain Structure of Vaccines
Figure 89. Channels of Distribution
Figure 90. Global Vaccines Sales Market Forecast by Region (2025-2030)
Figure 91. Global Vaccines Revenue Market Share Forecast by Region (2025-2030)
Figure 92. Global Vaccines Sales Market Share Forecast by Type (2025-2030)
Figure 93. Global Vaccines Revenue Market Share Forecast by Type (2025-2030)
Figure 94. Global Vaccines Sales Market Share Forecast by Application (2025-2030)
Figure 95. Global Vaccines Revenue Market Share Forecast by Application (2025-2030)
